|
Grape King Bio Ltd is a biotechnology company that develops health foods, energy drinks, and leisure beverages for all age groups. The company operates an OEM/ODM platform offering diverse dosage forms and professional consultation services. Its product portfolio includes the Kangbeit (康貝特) series, PowerBOMB, Grape King Kombucha, and probiotic supplements featuring the proprietary GKM3 strain. The firm also produces functional ingredients such as Hericium erinaceus mycelium powder, Cordyceps cicadae, and fungal protein products. Grape King Bio Ltd serves the consumer health market in Taiwan, partnering with brands like LAIMO for limited-edition products. The company holds patents in probiotics, Hericium erinaceus, and Cordyceps technologies, and operates the Grape King Biotechnology Research Institute. Summarised from the company's own disclosures |
Industry Packaged Foods | Homepage grapeking.com.tw |
| Sector Consumer Defensive | IR page grapeking.com.tw | |
|
Tags
health foods, energy drinks, kombucha, probiotics, functional ingredients, oem/odm, fungal protein, hericium erinaceus, cordyceps, Kangbeit, PowerBOMB, Grape King Kombucha, GKM3, GKLC1, GKBio Cordyceps Cicadae, Grape King Biotechnology Research Institute
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | NT$ 11.11B |
| Market cap (USD) | $ 337.219M |
| P/E | 10.45 |
| PEG | — |
| P/BV | 1.06 |
| P/S | 1.13 |
| P/OCF | 5.92 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 11.9% |
| ROI | 11.8% |
| ROIC | 16.8% |
| Profit margin | 11.9% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | -5.8% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 25.0% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.252B | 11.16B | 10.635B | 10.391B | 9.798B | 9.168B | 9.239B | 9.183B | 9.388B | 9.185B | 7.248B | 6.283B | 5.652B | 4.612B | 3.771B | 3.282B |
| Net profit | 1.218B | 1.448B | 1.453B | 1.457B | 1.3B | 1.272B | 1.309B | 1.295B | 1.352B | 1.297B | 1.052B | 942.483M | 835.762M | 618.902M | 473.062M | 427.7M |
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 126.5 | 149.5 | 156 | 168 | 160 | 177.5 | — | — | — | — | — | — | — | — | — | — |
| Price performance 12m | -0.15 | -0.04 | -0.07 | 0.05 | -0.1 | — | — | — | — | — | — | — | — | — | — | — |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpMaterial information published on MOPS, newest first, subjects as filed in Chinese, guarantee and loan balance notices and routine equipment purchases included. The link opens the company's material information on MOPS. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Grape King Bio Ltd
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVEE | 0.02% | 10,000 | $ 23.726K | Nov 16, 2026 |
| DFEM | 0.00% | 159,000 | $ 380.024K | Nov 12, 2026 |
| DFSE | 0.00% | 9,000 | $ 21.511K | Nov 12, 2026 |
| DFAE | 0.00% | 52,000 | $ 124.285K | Nov 12, 2026 |
| DFAX | 0.00% | 44,000 | $ 105.164K | Nov 12, 2026 |
| AVEM | 0.00% | 143,000 | $ 339.277K | Nov 16, 2026 |
| AVES | 0.00% | 11,000 | $ 26.098K | Nov 16, 2026 |
| AVSE | 0.00% | 4,000 | $ 9,490.28 | Nov 16, 2026 |
| AVXC | 0.00% | 7,000 | $ 16.608K | Nov 16, 2026 |









